Department of Laboratory Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.
Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Ann Lab Med. 2018 May;38(3):261-265. doi: 10.3343/alm.2018.38.3.261.
The 1B equation is recommended for calculating the glomerular filtration rate (GFR) in children. Since few reports have evaluated the performance of the 1B equation, we investigated the performance of estimated GFR (eGFR) equations with the blood urea nitrogen (BUN) variable for pediatric cancer patients. In total, 203 children with cancer who underwent measured GFR (mGFR) assessment were enrolled. The median (range) mGFR and eGFR calculated using the updated Schwartz equation were 118 (43-241) and 135 (34-257) mL/min/1.73 m², respectively. The bias, precision (root mean square error [RMSE]), and accuracy (P30, mGFR±30%) of three eGFR equations including updated Schwartz, 1B, and full age spectrum (FAS) were compared. The median bias (mL/min/1.73 m²) was: updated Schwartz, 8.5; 1B, -9.0; and FAS, 4.2. The biases for all three eGFR equations were significantly different from zero. The P30 was: updated Schwartz, 63.5%; 1B, 66.0%; and FAS, 66.0%. The RMSE was the lowest for the 1B equation (40.4), followed by FAS (42.3), and updated Schwartz (45.5). The median eGFR/mGFR ratio for the eGFR equations decreased with age and reduced kidney functions (i.e., increased creatinine and BUN concentrations). The bias may be further reduced by using the average from two equations, such as the updated Schwartz and 1B, or FAS equation, rather than using the updated Schwartz or 1B equation alone. The use of the 1B equation may underestimate the GFR. Using creatinine and BUN variables in the eGFR equation may yield a more accurate estimate of the GFR in pediatric cancer patients.
1B 方程推荐用于计算儿童的肾小球滤过率(GFR)。由于很少有报告评估 1B 方程的性能,我们研究了包含血尿素氮(BUN)变量的估计 GFR(eGFR)方程在儿科癌症患者中的表现。共纳入 203 例接受实测 GFR(mGFR)评估的癌症患儿。应用更新 Schwartz 方程计算的中位数(范围)mGFR 和 eGFR 分别为 118(43-241)和 135(34-257)mL/min/1.73m²。比较了包括更新 Schwartz 方程、1B 方程和全年龄谱(FAS)方程在内的 3 种 eGFR 方程的偏倚、精度(均方根误差 [RMSE])和准确性(P30,mGFR±30%)。中位数偏倚(mL/min/1.73m²)为:更新 Schwartz 方程为 8.5;1B 方程为-9.0;FAS 方程为 4.2。所有 3 种 eGFR 方程的偏倚均与零值有显著差异。P30 为:更新 Schwartz 方程为 63.5%;1B 方程为 66.0%;FAS 方程为 66.0%。RMSE 最低的是 1B 方程(40.4),其次是 FAS 方程(42.3)和更新 Schwartz 方程(45.5)。eGFR 方程的 eGFR/mGFR 比值随年龄和肾功能下降(即肌酐和 BUN 浓度升高)而降低。通过使用两个方程的平均值,例如更新 Schwartz 方程和 1B 方程,或者使用 FAS 方程,而不是单独使用更新 Schwartz 方程或 1B 方程,偏倚可能会进一步降低。1B 方程的使用可能会低估 GFR。在 eGFR 方程中使用肌酐和 BUN 变量可能会更准确地估计儿科癌症患者的 GFR。